<!DOCTYPE html>
<html lang="en">
    <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
        <title>10</title>

        <link href="bootstrap.min.css" rel="stylesheet">
        <link href="custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="treatments.css" rel="stylesheet" type="text/css"/>
        <link href="recreated_tables.css" rel="stylesheet" type="text/css"/>
           <style>
        .sep {
            border-bottom:1px solid lightgray;
        }
        .sep td {
            padding-bottom:5px;
            padding-top:5px;
        }
        br {
            display: block;
            margin-top: 5px 0;
        }
    </style>
    </head>
    <body>
        <div class="container"><h2>Special Considerations</h2>
<h3>Pregnancy</h3>
<p>Doxycycline is contraindicated in the second and third trimesters of pregnancy. Human data suggest ofloxacin and levofloxacin present a low risk to the fetus during pregnancy, with a potential for toxicity during breastfeeding; however, data from animal studies raise concerns about cartilage damage to neonates <sup id="fnref:317"><a class="footnote-ref" href="#fn:317" rel="footnote">1</a></sup>.  Thus, alternative drugs should be used to treat chlamydia in pregnancy. Clinical experience and published studies suggest that azithromycin is safe and effective <sup id="fnref:523"><a class="footnote-ref" href="#fn:523" rel="footnote">2</a></sup>  <sup id="fnref:524"><a class="footnote-ref" href="#fn:524" rel="footnote">3</a></sup>  <sup id="fnref:525"><a class="footnote-ref" href="#fn:525" rel="footnote">4</a></sup>. Test-of-cure to document chlamydial eradication (preferably by NAAT) 3-4 weeks after completion of therapy with the recommended regimens because severe sequelae can occur in mothers and neonates if the infection persists. In addition, all pregnant women diagnosed with a chlamydial infection should be retested 3 months after treatment. Detection of <em>C. trachomatis</em> infection at repeat screening during the third semester is not uncommon in adolescent and young adult women, including in those without <em>C. trachomatis</em> detected at the time of initial prenatal screening <sup id="fnref:526"><a class="footnote-ref" href="#fn:526" rel="footnote">5</a></sup>  <sup id="fnref:527"><a class="footnote-ref" href="#fn:527" rel="footnote">6</a></sup>. Women aged &lt;25 years and those at increased risk for chlamydia (e.g., those who have a new sex partner, more than one sex partner, a sex partner with concurrent partners, or a sex partner who has a sexually transmitted infection) should be rescreened during the third trimester to prevent maternal postnatal complications and chlamydial infection in the infant <sup id="fnref:108"><a class="footnote-ref" href="#fn:108" rel="footnote">7</a></sup>. </p>
<p>Because of concerns about chlamydia persistence following exposure to penicillin-class antibiotics that has been demonstrated in animal and in vitro studies, amoxicillin,  is now considered an alternative therapy for <em>C. trachomatis</em> in pregnant women <sup id="fnref:528"><a class="footnote-ref" href="#fn:528" rel="footnote">8</a></sup>  <sup id="fnref:529"><a class="footnote-ref" href="#fn:529" rel="footnote">9</a></sup>. The frequent gastrointestinal side effects associated with erythromycin can result in nonadherence with these alternative regimens. The lower dose 14-day erythromycin regimens can be considered if gastrointestinal tolerance is a concern. Erythromycin estolate is contraindicated during pregnancy because of drug-related hepatotoxicity.</p>
<div class="footnote">
<hr />
<ol>
<li id="fn:317">
<p>Briggs GC, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 9th ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2011.&#160;<a class="footnote-backref" href="#fnref:317" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
<li id="fn:523">
<p>Jacobson GF, Autry AM, Kirby RS, et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001;184:1352–4.&#160;<a class="footnote-backref" href="#fnref:523" rev="footnote" title="Jump back to footnote 2 in the text">&#8617;</a></p>
</li>
<li id="fn:524">
<p>Kacmar J, Cheh E, Montagno A, et al. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001;9:197–202.&#160;<a class="footnote-backref" href="#fnref:524" rev="footnote" title="Jump back to footnote 3 in the text">&#8617;</a></p>
</li>
<li id="fn:525">
<p>Rahangdale L, Guerry S, Bauer HM, et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006;33:106–10.&#160;<a class="footnote-backref" href="#fnref:525" rev="footnote" title="Jump back to footnote 4 in the text">&#8617;</a></p>
</li>
<li id="fn:526">
<p>Aggarwal A, Spitzer RF, Caccia N, et al. Repeat screening for sexually transmitted infection in adolescent obstetric patients. J Obstet Gynaecol Can 2010;32:956–61.&#160;<a class="footnote-backref" href="#fnref:526" rev="footnote" title="Jump back to footnote 5 in the text">&#8617;</a></p>
</li>
<li id="fn:527">
<p>Hood EE, Nerhood RC. The utility of screening for chlamydia at 34-36 weeks gestation. W V Med J 2010;106:10–1.&#160;<a class="footnote-backref" href="#fnref:527" rev="footnote" title="Jump back to footnote 6 in the text">&#8617;</a></p>
</li>
<li id="fn:108">
<p>LeFevre ML. USPSTF: screening for chlamydia and gonorrhea. Ann Intern Med 2014;161:902–10.&#160;<a class="footnote-backref" href="#fnref:108" rev="footnote" title="Jump back to footnote 7 in the text">&#8617;</a></p>
</li>
<li id="fn:528">
<p>Phillips Campbell R, Kintner J, Whittimore J, et al. Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice. Microbes and Infection 2012;14:1177–85.&#160;<a class="footnote-backref" href="#fnref:528" rev="footnote" title="Jump back to footnote 8 in the text">&#8617;</a></p>
</li>
<li id="fn:529">
<p>Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010;201(Suppl 2):S88–95.&#160;<a class="footnote-backref" href="#fnref:529" rev="footnote" title="Jump back to footnote 9 in the text">&#8617;</a></p>
</li>
</ol>
</div>
        </div>
            </div>
        </div>
    </body>
</html>
        